Birgit Gaschler‐Markefski

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck, R. Kaiser, Anders Mellemgaard et al. · The Lancet Oncology · 2014 · 931 citations · Full text

Oncology, Nintedanib Versus Docetaxel, Lume-lung 1 +10

Lateralized auditory spatial perception and the contralaterality of cortical processing as studied with functional magnetic resonance imaging and magnetoencephalography

Marty G. Woldorff, Claus Tempelmann, Juergen Fell et al. · Human Brain Mapping · 1999 · 177 citations · Full text

Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors

K. Mross, Martin Štefanič, Daniela Gmehling et al. · Clinical Cancer Research · 2009 · 164 citations

Electrodynamic headphones and woofers for application in magnetic resonance imaging scanners

Frank Baumgart, Thomas Kaulisch, Claus Tempelmann et al. · Medical Physics · 1998 · 114 citations

The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from an Open-Label, Randomized Phase II Clinical Trial

Martin Sebastian, Martin Reck, Cornelius F. Waller et al. · Journal of Thoracic Oncology · 2010 · 109 citations · Full text

Bi 2536, Novel Plk-1 Inhibitor, Medicine +6